Cassava Sciences Inc (SAVA)
2.36
+0.07
(+3.06%)
USD |
NASDAQ |
Dec 20, 16:00
2.34
-0.02
(-0.85%)
After-Hours: 20:00
Cassava Sciences Total Assets (Quarterly): 223.75M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
Bristol-Myers Squibb Co | 93.67B |
BridgeBio Pharma Inc | 664.98M |
Seelos Therapeutics Inc | 2.381M |
Alnylam Pharmaceuticals Inc | 4.205B |
EyePoint Pharmaceuticals Inc | 300.92M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 57.11M |
Shareholders Equity (Quarterly) | 166.64M |